Product Information
Registration Status: ActiveFASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5mg/VIAL is approved to be sold in Singapore with effective from 2002-08-27. It is marketed by SANOFI-AVENTIS SINGAPORE PTE LTD, with the registration number of SIN12055P.
This product contains Rasburicase 1.5mg/vial in the form of INJECTION, POWDER, FOR SOLUTION. It is approved for INTRAVENOUS use.
This product is manufactured by SANOFI WINTHROP INDUSTRIE (Solvent manufacturer) in FRANCE, andGLAXO WELLCOME PRODUCTION (Powder manufacturer) in ITALY.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Description
Rasburicase is a recombinant urate-oxidase enzyme produced by a genetically modified Saccharomyces cerevisiae strain. The cDNA coding for rasburicase was cloned from a strain of Aspergillus flavus.
Indication
For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy)
Mechanism of Action
Rasburicase catalyzes enzymatic oxidation of uric acid into an inactive and soluble metabolite (allantoin).
Active Ingredient/Synonyms
Urate oxidase | Uricase | Rasburicase |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.